| Primary |
| Hypertension |
44.9% |
| Product Used For Unknown Indication |
18.4% |
| Non-hodgkin's Lymphoma |
8.2% |
| Cerebrovascular Accident |
4.1% |
| Hypothyroidism |
4.1% |
| Tachycardia |
4.1% |
| Cerebrovascular Accident Prophylaxis |
2.0% |
| Convulsion |
2.0% |
| Depression |
2.0% |
| Essential Hypertension |
2.0% |
| Joint Swelling |
2.0% |
| Myocardial Ischaemia |
2.0% |
| Orthostatic Hypotension |
2.0% |
| Prophylaxis |
2.0% |
|
| Visual Acuity Reduced |
16.7% |
| Hyponatraemia |
8.3% |
| Liver Function Test Abnormal |
8.3% |
| Osmotic Demyelination Syndrome |
8.3% |
| Pemphigoid |
8.3% |
| Primary Hyperaldosteronism |
8.3% |
| Diarrhoea |
4.2% |
| Hypokalaemia |
4.2% |
| Hypovolaemia |
4.2% |
| Inappropriate Antidiuretic Hormone Secretion |
4.2% |
| Lethargy |
4.2% |
| Loss Of Consciousness |
4.2% |
| Muscular Weakness |
4.2% |
| Pancreatitis Acute |
4.2% |
| Skin Ulcer |
4.2% |
| Syncope |
4.2% |
|
| Secondary |
| Hypertension |
25.0% |
| Product Used For Unknown Indication |
21.8% |
| Drug Use For Unknown Indication |
15.6% |
| Diabetes Mellitus |
5.7% |
| Hypercholesterolaemia |
3.7% |
| Left Ventricular Failure |
2.5% |
| Breakthrough Pain |
2.4% |
| Fluid Overload |
2.4% |
| Phantom Pain |
2.4% |
| Prophylaxis |
2.4% |
| Depression |
2.3% |
| Angina Pectoris |
2.1% |
| Asthma |
1.9% |
| Polyuria |
1.7% |
| Atrial Fibrillation |
1.5% |
| Pain |
1.5% |
| Type 2 Diabetes Mellitus |
1.5% |
| Breast Cancer |
1.4% |
| Arthralgia |
1.0% |
| Epilepsy |
1.0% |
|
| Vomiting |
14.1% |
| Somnolence |
13.7% |
| Jaundice |
10.6% |
| Hyponatraemia |
7.9% |
| Renal Failure Acute |
7.5% |
| Pancreatitis Acute |
5.7% |
| Syncope |
4.4% |
| Urine Oxalate Increased |
4.0% |
| Inappropriate Antidiuretic Hormone Secretion |
3.5% |
| Liver Function Test Abnormal |
3.5% |
| Pyrexia |
3.5% |
| Renal Impairment |
3.1% |
| Lethargy |
2.6% |
| Tetany |
2.6% |
| Dehydration |
2.2% |
| Hypomagnesaemia |
2.2% |
| Hypotension |
2.2% |
| Orthostatic Hypotension |
2.2% |
| Overdose |
2.2% |
| Pancreatitis |
2.2% |
|
| Concomitant |
| Product Used For Unknown Indication |
38.9% |
| Hypertension |
19.0% |
| Drug Use For Unknown Indication |
17.8% |
| Rheumatoid Arthritis |
3.4% |
| Pain |
2.3% |
| Prophylaxis |
2.2% |
| Hypercholesterolaemia |
2.0% |
| Depression |
1.8% |
| Diabetes Mellitus |
1.7% |
| Type 2 Diabetes Mellitus |
1.4% |
| Blood Cholesterol Increased |
1.2% |
| Blood Pressure Increased |
1.1% |
| Atrial Fibrillation |
1.0% |
| Hiv Infection |
1.0% |
| Asthma |
1.0% |
| Osteoporosis |
0.9% |
| Blood Pressure |
0.9% |
| Constipation |
0.8% |
| Osteoarthritis |
0.8% |
| Hypothyroidism |
0.8% |
|
| Vomiting |
12.8% |
| Renal Failure Acute |
11.1% |
| Vision Blurred |
6.1% |
| Weight Decreased |
5.5% |
| Swelling Face |
4.9% |
| Rhabdomyolysis |
4.6% |
| Swollen Tongue |
4.5% |
| Urinary Tract Infection |
4.3% |
| Weight Increased |
4.3% |
| Epilepsy |
4.2% |
| Visual Impairment |
4.2% |
| Fall |
4.1% |
| Pain In Extremity |
4.1% |
| Nausea |
3.8% |
| Pain |
3.8% |
| Syncope |
3.8% |
| Malaise |
3.5% |
| Wheezing |
3.5% |
| Myocardial Infarction |
3.4% |
| Renal Impairment |
3.3% |
|
| Interacting |
| Hypertension |
23.8% |
| Drug Use For Unknown Indication |
23.2% |
| Depression |
11.6% |
| Product Used For Unknown Indication |
11.6% |
| Tooth Disorder |
6.1% |
| Prophylaxis |
4.3% |
| Diabetes Mellitus |
3.7% |
| Multiple Myeloma |
2.4% |
| Gout |
1.8% |
| Ill-defined Disorder |
1.8% |
| Aortic Aneurysm |
1.2% |
| Cardiac Failure Congestive |
1.2% |
| Heart Rate Irregular |
1.2% |
| Irritable Bowel Syndrome |
1.2% |
| Pain |
1.2% |
| Type 2 Diabetes Mellitus |
1.2% |
| Alcohol Use |
0.6% |
| Antiviral Prophylaxis |
0.6% |
| Atrial Fibrillation |
0.6% |
| Lung Adenocarcinoma |
0.6% |
|
| Sedation |
14.3% |
| Inappropriate Antidiuretic Hormone Secretion |
11.4% |
| Renal Failure Acute |
11.4% |
| Vomiting |
11.4% |
| Drug Interaction |
8.6% |
| Blood Sodium Decreased |
5.7% |
| Feeling Hot |
5.7% |
| Hyponatraemia |
5.7% |
| Transient Ischaemic Attack |
5.7% |
| Circulatory Collapse |
2.9% |
| Coma |
2.9% |
| Convulsion |
2.9% |
| Gait Disturbance |
2.9% |
| Memory Impairment |
2.9% |
| Osmotic Demyelination Syndrome |
2.9% |
| Renal Impairment |
2.9% |
|
